Drug-eluting coronary stents

被引:37
作者
Salam, AM [1 ]
Al Suwaidi, J [1 ]
Holmes, DR [1 ]
机构
[1] Hamad Gen Hosp, Cardiac Catheterizat Lab, Doha, Qatar
关键词
D O I
10.1016/j.cpcardiol.2005.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty. This angiographic restenosis was further reduced with the introduction of drug-eluting stents and hence further reduction in the frequency of major adverse cardiac events. Herein we present a comprehensive and up-to-date review about the use of drug-eluting stents in the treatment of coronary artery disease.
引用
收藏
页码:8 / 119
页数:112
相关论文
共 369 条
[151]   Prevention of restenosis after coronary angioplasty [J].
Karthikeyan, G ;
Bhargava, B .
CURRENT OPINION IN CARDIOLOGY, 2004, 19 (05) :500-509
[152]   Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions [J].
Kastrati, A ;
Schömig, A ;
Elezi, S ;
Schühlen, H ;
Wilhelm, M ;
Dirschinger, J .
CIRCULATION, 1998, 97 (24) :2396-2401
[153]   P1A polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement [J].
Kastrati, A ;
Schömig, A ;
Seyfarth, M ;
Koch, W ;
Elezi, S ;
Böttiger, C ;
Mehilli, J ;
Schömig, K ;
von Beckerath, N .
CIRCULATION, 1999, 99 (08) :1005-1010
[154]   Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis -: A randomized controlled trial [J].
Kastrati, A ;
Mehilli, J ;
von Beckerath, N ;
Dibra, A ;
Hausleiter, J ;
Pache, J ;
Schühlen, H ;
Schmitt, C ;
Dirschinger, J ;
Schömig, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (02) :165-171
[155]  
KASTRATI A, 2005 ACC SCI SESS OR
[156]  
KELBAECK H, 2005 ACC SCI SESS OR
[157]   Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials) [J].
Kereiakes, D ;
Linnemeier, TJ ;
Baim, DS ;
Kuntz, R ;
O'Shaughnessy, C ;
Hermiller, J ;
Fink, S ;
Lansky, A ;
Nishimura, N ;
Broderick, TM ;
Popma, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (03) :336-+
[158]  
Kereiakes D, 2003, CIRCULATION, V108, P532
[159]  
Khoja A, 1997, CATHETER CARDIO DIAG, V41, P192, DOI 10.1002/(SICI)1097-0304(199706)41:2<192::AID-CCD19>3.0.CO
[160]  
2-S